Working smarter with data – digital transformation in a traditional SME manufacturer

@AuManufacturing‘s editorial series, ‘Working smarter with data‘, continues today with a look at digital implementation at 94-year old company Everhard Industries. Here Peter Roberts talks to IT leader Steve Dobe who made the transformation happen. It is hard to imagine a more traditional business than Geebung, Queensland’s Everhard Industries. From its roots in the 1920s…

Amaero international, PPK and Deakin collaborate to develop super alloys

Advanced materials group PPK, additive manufacturing technology company Amaero International and Deakin University have joined forces to develop new, super strong aluminium alloys. The three have established a joint venture research company, Strategic Alloys Pty Ltd, to formulate the new alloys which will be reinforced by boron nitride nanotubes (BNNT) which act as a nano-reinforcement…

Rowlands buys AML3D robotic additive manufacturing module

Sheet metal fabricator Rowlands Metalworks has become the second company to purchase an AML3D 3D Arcemy Robotic Welding Cell. The purchase, which gives important third party validation to AML3D’s 3D Wire Additive Manufacturing technologies, will boost Rowlands’ move into higher value defence and agricultural technology products. AML3D delivered the first Arcemy 3D printer to aerospace…

Luck or leverage? How Australian manufacturers can use innovation and incentives to make local products more attractive to export markets

We have long been internationally admired for our low levels of debt, high standards of living and a consistently safe and stable environments in which to live and work. We are indeed the lucky country but if we hope to retain that title, we face a choice: to continue safely along this well-worn path or to strike out and forge a new path.

CSL begins Covid vaccine manufacture in Melbourne today

CSL will begin manufacturing the University of Oxford/AstraZeneca AZD1222 Covid-19 vaccine candidate at its advanced manufacturing facility in Broadmeadows in northern Melbourne today. The high-tech biotechnology plant (pictured) is contracted to AstraZeneca and the Australian Government to manufacture approximately 30 million doses of the AZD1222 vaccine candidate. In a statement the company said first doses…